Prof. Dr. ORHAN TANSEL KORKMAZ

Yayın Ağı

Makaleler 20

1. Vasoactive Intestinal Peptide (VIP) and its Receptors in Adipose Tissue: Implications for Cold Stress Adaptation

KORKMAZ O. T., SAYDAM F., Dalkiran B., DEĞİRMENCİ İ., Tunçel N.

Cell Biochemistry and Biophysics , cilt.83, sa.2, ss.1963-1972, 2025 (SCI-Expanded, Scopus)

2. Investigation of the Neuroprotective Effect of Riluzole on Matrix Metalloproteinases in an Experimental Model of Glaucoma

Yıldız F., Şahinoğlu Keşkek N., Yılmaz I. T., Candan İ. A., Korkmaz O. T.

Journal of Current Ophthalmology , cilt.36, sa.2, ss.136-144, 2025 (ESCI, Scopus)

3. Increased Serotonin Levels and Unchanged Glutamate and GABA Levels in Thalamic Microdialysates Despite Reduced Cell Numbers in a Valproic Acid-Induced Autism Model

Ay H., Horata E., Kaya E. M. Ö., Korkmaz O. T.

NEUROCHEMICAL RESEARCH , cilt.50, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Neuroprotective Effects of Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activating Polypeptide-38 (PACAP-38) in Amyotrophic Lateral Sclerosis (ALS) Mouse Model

Yilmaz I. T., KORKMAZ O. T., KUŞ G., Kaya E. M. O., MERAL EVİŞ C. C., ESER M., et al.

ACTA PHYSIOLOGICA , ss.24, 2023 (SCI-Expanded, Scopus)

5. The Effects of Carvacrol on Transient Receptor Potential (TRP) Channels in an Animal Model of Parkinson's Disease

Akan T., AYDIN Y., KORKMAZ O. T., ULUPINAR E., SAYDAM F.

NEUROTOXICITY RESEARCH , cilt.41, sa.6, ss.660-669, 2023 (SCI-Expanded, Scopus)

6. Vasoactive Intestinal Peptide Differentially Modulates Neurogenesis in Experimental Parkinson's Disease Models

MERAL EVİŞ C. C., KORKMAZ O. T., Tuncel N.

ACTA PHYSIOLOGICA , ss.62, 2023 (SCI-Expanded, Scopus)

7. Can Brain-derived Neurotrophic Factor (BDNF) Mimetics be a Way Out for Neurodegenerative Diseases?

KORKMAZ O. T.

Current Pharmaceutical Design , cilt.29, sa.4, ss.246-250, 2023 (SCI-Expanded, Scopus)

8. Investigation of the pharmacokinetic properties and theoretical chemical activities of 7,8-dihydroxyflavone and 4'-dimethylamino-7,8-dihydroxyflavone

Karakaya M. F., Gokalp F., ŞENER E., KORKMAZ O. T.

Current Pharmaceutical Analysis , cilt.19, sa.4, ss.317-323, 2023 (SCI-Expanded, Scopus)

9. Vasoactive intestinal peptide (VIP) conducts the neuronal activity during absence seizures: GABA seems to be the main mediator of VIP

KORKMAZ O. T., Arkan S., Öncü-Kaya E. M., ATEŞ N., Tunçel N.

Neuroscience Letters , cilt.765, 2021 (SCI-Expanded, Scopus)

10. Determination of Ochratoxin-A in the brain microdialysates and plasma of awake, freely moving rats using ultra high performance liquid chromatography fluorescence detection method

Kaya E. M. O., KORKMAZ O. T., Ugur D. Y., ŞENER E., Tuncel A. N., Tuncel M.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES , cilt.1125, 2019 (SCI-Expanded, Scopus)

11. Vasoactive Intestinal Peptide Decreases -Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease

Korkmaz O. T., Ay H., Aytan N., Carreras I., Kowall N. W., Dedeoglu A., et al.

JOURNAL OF MOLECULAR NEUROSCIENCE , cilt.68, sa.3, ss.389-396, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease

KORKMAZ O. T., Tuncel N.

CURRENT PHARMACEUTICAL DESIGN , cilt.24, sa.39, ss.4693-4701, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats

Yelkenli I. H., Ulupınar E., Korkmaz O. T., Şener E., Kuş G., Filiz Z., et al.

JOURNAL OF MOLECULAR NEUROSCIENCE , cilt.59, ss.280-289, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

14. 7,8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis

KORKMAZ O. T., Aytan N., Carreras I., Choi J., Kowall N. W., Jenkins B. G., et al.

NEUROSCIENCE LETTERS , cilt.566, ss.286-291, 2014 (SCI-Expanded, Scopus)

15. Vasoactive Intestinal Peptide Enhances Striatal Plasticity and Prevents Dopaminergic Cell Loss in Parkinsonian Rats

Korkmaz O. T., Ay H., Ulupınar E., Tuncel N.

JOURNAL OF MOLECULAR NEUROSCIENCE , cilt.48, sa.3, ss.565-573, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Antioxidant and Anti-Apoptotic Activity of Vasoactive Intestinal Peptide (VIP) Against 6-Hydroxy Dopamine Toxicity in the Rat Corpus Striatum

Tuncel N., KORKMAZ O. T., Tekin N., ŞENER E., AKYÜZ F., Inal M.

JOURNAL OF MOLECULAR NEUROSCIENCE , cilt.46, sa.1, ss.51-57, 2012 (SCI-Expanded, Scopus)

17. A simple and sensitive LC-ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates

YENİCELİ D., ŞENER E., KORKMAZ O. T., Dogrukol-Ak D., Tuncel N.

TALANTA , cilt.84, sa.1, ss.19-26, 2011 (SCI-Expanded, Scopus)

18. Vasoactive Intestinal Peptide (VIP) Treatment of Parkinsonian Rats Increases Thalamic Gamma-Aminobutyric Acid (GABA) Levels and Alters the Release of Nerve Growth Factor (NGF) by Mast Cells

KORKMAZ O. T., Tuncel N., Tuncel M., Oncu E. M., ŞAHİNTÜRK V., Celik M.

JOURNAL OF MOLECULAR NEUROSCIENCE , cilt.41, sa.2, ss.278-287, 2010 (SCI-Expanded, Scopus)

19. The Effects of Vasoactive Intestinal Peptide on Dura Mater Nitric Oxide Levels and Vessel-Contraction Responses in Sympathectomized Rats

TÖRE F., KORKMAZ O. T., Dogrukol-Ak D., Tuncel N.

JOURNAL OF MOLECULAR NEUROSCIENCE , cilt.41, sa.2, ss.288-293, 2010 (SCI-Expanded, Scopus)

20. Determination of carbamazepine and its main metabolite carbamazepine-10, 11-epoxide in rat brain microdialysate and blood using ESI-LC-MS (ion trap)

Sener E., KORKMAZ O. T., Yeniceli D., Do'grukol-Ak D., Tuncel M., Tuncel N.

CHROMATOGRAPHIA , cilt.66, 2007 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 36

1. Parkinson Hastalığı ve TRP Kanallarının İlişkisi; Karvakrol'ün Olası Tedavi Edici Etkileri

Koca T., Aydın Y., Korkmaz O. T., Ulupınar E., Saydam F.

47.Ulusal Fizyoloji Kogresi, Antalya, Türkiye, 1 - 04 Kasım 2022, ss.75, (Özet Bildiri)

2. Therapeutic efficacy of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in amyotrophic lateral sclerosis (ALS) mouse model

Yılmaz I. T., KORKMAZ O. T., KUŞ G., ÖNCÜ KAYA E. M., MERAL EVİŞ C. C., ESER M., et al.

The 15th International Symposium on VIP, PACAP and Related Peptides, Osaka, Japonya, 30 Ekim 2022, (Özet Bildiri)

3. Investigation of the effects of 7,8-Dihydroxyflavone on motor neurons in amyotrophic lateral sclerosis model mice

KORKMAZ O. T.

HODJA AKHMET YASSAWI 6th International Conference on Scientific Research, Lankaran, Azerbaycan, 13 Mayıs 2022, (Özet Bildiri)

4. Bir seramidöz inhibitörü olan N-Oleoylethanolamine bileşiğinin AS49 ve Beas-2B hücreleri üzerindeki sitotoksik ve morfolojik değişimlerinin araştırılması

ÇÖMLEKÇİ E., İZGÖRDÜ H., VEJSELOVA SEZER C., KORKMAZ O. T., KUTLU H. M.

1. INTERNATIONAL MULTIDISCIPLINARY CANCER RESEARCH CONGRESS, 18 - 22 Eylül 2019, (Tam Metin Bildiri)

5. LC-MS/MS Method for the Determination of Lamotrigine in Human Plasma

ŞENER E., AK D., KORKMAZ O. T.

INTERNATIONAL CHEMISTRY BIOLOGY CONFERENCE’19, 1 - 05 Ağustos 2019, (Tam Metin Bildiri)

6. Development of UHPLC-FLD method for the determination of T-2 and HT-2 toxins in rat plasma and brain microdialysate samples

ÖNCÜ KAYA E. M., KORKMAZ O. T., Sener Z. A.

8th Black Sea Basin Conference on Analytical Chemistry, İstanbul, Türkiye, 9 - 11 Mayıs 2018, (Özet Bildiri)

7. VASOACTIVE INTESTINAL PEPTIDE (VIP) DECREASES β-AMYLOIDACCUMULATION AND PREVENTS BRAIN ATROPHY IN 5XFAD MOUSEMODEL OF ALZHEIMER’S DISEASE

KORKMAZ O. T., AY H., AYTAN N., CARRERAS I., KOWALL N., DEDEOĞLU A., et al.

13. Inetrnetional Symposium on VIP, PACAP and related peptides, 3 - 07 Aralık 2017, (Özet Bildiri)

8. VIP, VPAC-1 AND VPAC-2 EXPRESSION IN ADIPOCYTES CELLS OFINTERSCAPULAR AND SUBCUTANEOUS TISSUE: EFFECTS OF COLDEXPOSURE

DEMİRBAŞ B., KORKMAZ O. T., SAYDAM F., CHALDAKOV G., TUNÇEL A. N.

13. International Symposium on VIP, PACAP and Related Peptides, 3 - 07 Aralık 2017, (Özet Bildiri)

9. Determination of Mycotoxin in Rat Plasma Samples by Ultra High Performance Liquid Chromatography with Fluorescence Detection

ÖNCÜ KAYA E. M., KORKMAZ O. T., YENİCELİ UĞUR D., TUNÇEL A. N., TUNCEL M., AKDER O.

10th Aegean Analytical Chemistry Days, Çanakkale, Türkiye, 29 Eylül - 02 Ekim 2016, (Özet Bildiri)

10. A Simple and Sensitive UHPLC Method for The Determination oc Ochratoxin A and Its Application to Biological Samples

ÖNCÜ KAYA E. M., KORKMAZ O. T., AKDERE O., YENİCELİ UĞUR D., TUNÇEL A. N., TUNCEL M.

28. Ulusal Kimya Kongresi, Mersin, Türkiye, 15 - 21 Ağustos 2016, (Özet Bildiri)

11. Alteration of VIP VPAC1 and VPAC2 gene expression in brown and white adipose tissues of the rats during cold exposure

KORKMAZ O. T., DEMIRBAS B., SAYDAM F., DEĞİRMENCİ İ., CHALDAKOV G., TUNÇEL A. N.

Regulatory Peptides 2016, 11 - 15 Temmuz 2016, (Özet Bildiri)

12. The effects of vasoactive intestinal peptid VIP on absence epilepsy

ARKAN S., KORKMAZ O. T., KARSON A., ATEŞ N., TUNÇEL A. N.

The 10th FENS Forum of Neuroscience, 2 - 06 Temmuz 2016, (Özet Bildiri)

13. The choronic and acute effects of VIP on absence seizures

ARKAN S., KORKMAZ O. T., KARSON A., ATEŞ N., TUNÇEL A. N.

12th International Symposium on VIP-PACAP and related peptides, Nevşehir, Türkiye, 21 - 26 Eylül 2015

14. LC MS MS method for the determination of levetiracetam in rat brain microdialysate

AK D., ŞENER E., KORKMAZ O. T., GENÇ L.

11th International Symposium on Pharmaceutical Sciences, 9 - 12 Haziran 2015, (Tam Metin Bildiri)

15. The effects of VIP application on somatosensorial cortex of WAG Rij rats

KORKMAZ O. T., ÖNCÜ KAYA E. M., ARKAN S., KARSON A., ATEŞ N., TUNÇEL A. N., et al.

12th International Symposium on VIP-PACAP and Related Peptides, Nevşehir, Türkiye, 21 - 26 Eylül 2015

16. Modulated corpus striatal neurochemistry by 6 OHDA astrocytes and VIP in parkinsonian rats astrocytes are vanguard defensive cell and VIP prefers neurons to induce ADNP and GAD

ULUPINAR E., yelkenli i., KORKMAZ O. T., ŞENER E., KUŞ G., FİLİZ Z., et al.

12th International Symposium on VIP-PACAP and Related Peptides, 21 - 26 Eylül 2015, (Özet Bildiri)

17. LC MS MS method devolopment for the new antiepileptic drugs from patient s blood

ŞENER E., AK D., KORKMAZ O. T., TORUN Ş., GENÇ L., TUNÇEL A. N.

HPLC 2014, New Orleans, Amerika Birleşik Devletleri, 11 - 15 Mayıs 2014, (Özet Bildiri)

18. Simultaneous determination of zonasamide carbamazepine phenytoin and ethosuximide by LC PDA in rat plasma

ŞENER E., KIRAL M., BEKTAŞ TÜRKMEN N., KORKMAZ O. T., YENİCELİ D.

HPLC 2014, New Orleans, Amerika Birleşik Devletleri, 11 - 15 Mayıs 2014, (Özet Bildiri)

19. CRITICAL ROLE OF ASTROCYTES ON STRIATAL NEURO-CHEMISTRY IN VIP TREATED PARKINSONIAN RATS

Tuncel N., Yelkenli I., Ulupinar E., Korkmaz O. T., Sener E., Kus G.

21st Annual Meeting of the Israel-Society-for-Neuroscience / 1st Binational Australian-Israeli Meeting on Neuroscience, Eilat, İsrail, 15 Aralık 2012, cilt.51, (Özet Bildiri)

20. Voltammetric determination of neurotransmitter dopamine in rat brain microdilysate at a carbon paste electrode moified with poly glutamic acid

TALAY PINAR P., ŞENTÜRK Z., TUNÇEL A. N., KORKMAZ O. T.

10th international electrochemistry meeting in Turkey, Konya, Türkiye, 4 - 08 Eylül 2013

21. Electrochemical determination of neurotransmitter serotonin in rat brain microdialysate using poly glutamic acid modified carbon electrode

TALAY PINAR P., ŞENTÜRK Z., TUNÇEL A. N., KORKMAZ O. T.

XVII European conference on analytical chemistry ( Euroanalysis 2013), Warszawa, Polonya, 25 - 29 Ağustos 2013

22. Antioxidant and anti-apoptotic activity of Vasoactive Intestinal Peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum

Korkmaz O. T., Tuncel N., Tekin N., ŞENER E., AKYÜZ F., Inal M.

Summer Neuropeptide Conference / Meeting of the European-Neuropeptide-Club (ENC), Massachusetts, Amerika Birleşik Devletleri, 22 - 25 Mayıs 2011, cilt.48, (Özet Bildiri)

23. Vasoactive Intestinal Peptide (VIP) enhances the striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats

Tuncel N., KORKMAZ O. T., ULUPINAR E., AY H.

10th International Symposium on VIP-PACAP and Related Peptides, Eilat, İsrail, 13 - 16 Aralık 2011, cilt.48, (Özet Bildiri)

24. 7 8 Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis

KORKMAZ O. T.

Neuroscience 2012, New Orleans, Amerika Birleşik Devletleri, 15 - 19 Ekim 2012, (Tam Metin Bildiri)

25. A simple and sensitive LC ESI MS method for the determination of bupropion and its major metabolite hydroxybupropion in fat plasma and brain microdialysates

YENİCELİ D., ŞENER E., KORKMAZ O. T., AK D., TUNÇEL A. N.

10th International symposium on pharmaceutical sciences, Ankara, Türkiye, 26 - 29 Haziran 2012, (Tam Metin Bildiri)

26. Vasoactive Intestinal Peptide Enhances Striatal Plasticity and Prevents Dopaminergic Cell Loss in Parkinsonian Rats

TUNÇEL A. N., KORKMAZ O. T., AY H., ULUPINAR E.

10th International symposium on VIP-PACAP and related peptides, Eliat, İsrail, 13 - 16 Aralık 2011, (Özet Bildiri)

27. Anti oxidant and anti apoptotic actions of vasoactive intestinal peptide on the parkinsonian rats

KORKMAZ O. T., TEKİN N., ŞENER E., TUNÇEL A. N., AKYÜZ F., İNAL M.

European neuropeptide conferance, Boston, 22 - 25 Mayıs 2011, (Özet Bildiri)

28. Antioxidant and anti-apopototic activity of vasoactive ıntestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum

KORKMAZ O. T., TUNÇEL N., TEKİN N., ŞENER E., AKYÜZ F., İNAL M.

Summer Neuropeptide Conference and the Eropean Neuropeptide Club (ENC) Meeting, 22 - 25 Mayıs 2011, ss.173-201, (Özet Bildiri)

29. Vazoaktif intestinal peptidin dünü bugünü ve yarını

TUNÇEL A. N., KORKMAZ O. T.

36. Ulusal Fizyoloji Kongresi, Edirne, Türkiye, 14 - 17 Eylül 2010, (Tam Metin Bildiri)

30. Deneysel Parkinson modelinde vazoaktif intestinal peptit (VIP)’xxin antioksidan ve antiapoptotik etkileri

KORKMAZ O. T., TEKİN N., ŞENER E., TUNÇEL N., AKYÜZ F., İNAL M.

9.Ulusal Sinirbilimleri Kongresi, Türkiye, 13 - 17 Nisan 2010, cilt.16, ss.140, (Özet Bildiri)

31. The effects of vasoactive intestinal peptide on dura mater nitric oxide levels and vessel contraction responses in sympathectomized rats

TÖRE F., KORKMAZ O. T., TUNÇEL A. N., ŞENER E.

8. Ulusal Sinirbilim Kongresi, Bolu, Türkiye, 20 - 24 Nisan 2009, (Tam Metin Bildiri)

32. VASOACTIVE INTESTINAL PEPTIDE (VIP) TREATMENT OF PARKINSONIAN RATS INCREASES IN THALAMIC GAMMA AMINO BUTYRIC ACID (GABA) LEVELS, AND CHANGES NERVE GROWTH FACTOR (NGF) RELEASE OF BRAIN MAST CELLS

Tuncel N., KORKMAZ O. T., Tuncel M., Oncu E. M., Sahinturk V., Celik M.

Joint Meeting of the European-Neuropeptides-Club/Summer Neuropeptides Conference, Salzburg, Avusturya, 20 - 23 Temmuz 2009, cilt.43, ss.424, (Özet Bildiri)

33. THE EFFECTS OF VASOACTIVE INTESTINAL PEPTIDE ON DURAMATER NITRIC OXIDE LEVELS AND VESSEL-CONTRACTION RESPONSES AT SYMPATHECTOMIZED RATS

Tore F., Korkmaz O. T., Dogrukol-Ak D., Tuncel N.

Joint Meeting of the European-Neuropeptides-Club/Summer Neuropeptides Conference, Salzburg, Avusturya, 20 - 23 Temmuz 2009, cilt.43, ss.413-414, (Özet Bildiri) Sürdürülebilir Kalkınma